Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients - Discussion - Dr. Nutt

被引：0
|
作者：
Obeso
Nutt
Reichmann
Olanow
Lieberman
Koller
Fahn
Gordin
Waters
Dingemanse
Reichmann
Brooks
Guttman
Hauser
机构：
来源：
NEUROLOGY | 2000年 / 55卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S38 / S41
页数：4
相关论文
共 50 条
  • [1] Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients
    Nutt, JG
    [J]. NEUROLOGY, 2000, 55 (11) : S33 - S37
  • [2] Benefits of COMT inhibitors in levodopa-treated parkinsonian patients - Results of clinical trials - Discussion - Dr. Kieburtz
    Kieburtz
    Olanow
    Hubble
    Obeso
    Dingemanse
    Waters
    Schapira
    Stocchi
    Rascol
    Ventura
    Koller
    LeWitt
    [J]. NEUROLOGY, 2000, 55 (11) : S46 - S50
  • [3] LEVODOPA PHARMACOKINETICS AND PHARMACODYNAMICS IN FLUCTUATING PARKINSONIAN-PATIENTS
    NUTT, JG
    WOODWARD, WR
    [J]. NEUROLOGY, 1986, 36 (06) : 739 - 744
  • [4] Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients
    Triggs, EJ
    Charles, BG
    Contin, M
    Martinelli, P
    Cortelli, P
    Riva, R
    Albani, F
    Baruzzi, A
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (01) : 59 - 67
  • [5] EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS
    NUTT, JG
    WOODWARD, WR
    BECKNER, RM
    STONE, CK
    BERGGREN, K
    CARTER, JH
    GANCHER, ST
    HAMMERSTAD, JP
    GORDIN, A
    [J]. NEUROLOGY, 1994, 44 (05) : 913 - 919
  • [6] COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients on levodopa/carbidopa (Sinemet®)
    Jorga, KM
    Nicholl, DJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (03) : 449 - 452
  • [7] PHARMACODYNAMICS OF THE HYPOTENSIVE EFFECT OF LEVODOPA IN PARKINSONIAN-PATIENTS
    IRWIN, RP
    NUTT, JG
    WOODWARD, WR
    GANCHER, ST
    [J]. CLINICAL NEUROPHARMACOLOGY, 1992, 15 (05) : 365 - 374
  • [8] Issues important for rational COMT inhibition - Discussion - Dr. Dingemanse
    Waters
    Dingemanse
    Schapira
    Nutt
    Obeso
    Schapira
    Olanow
    Stocchi
    Gordin
    Rascol
    Koller
    Hauser
    LeWitt
    Jenner
    Hubble
    [J]. NEUROLOGY, 2000, 55 (11) : S28 - S32
  • [9] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C. W.
    Kieburtz, K. D.
    Liang, G. S.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S7 - S7
  • [10] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C.
    Kieburtz, K.
    Liang, G.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S62 - S62
12345